Clinical Trial Detail

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT06171685
Title	MMRC Horizon One Adaptive Platform Trial Evaluating Therapies in RRMM
Recruitment	Recruiting
Gender	both
Phase	Phase II
Variant Requirements	No
Sponsors	Multiple Myeloma Research Consortium
Indications	multiple myeloma
Therapies	Teclistamab
Age Groups:	adult \| senior
Covered Countries	USA

Facility	Status	City	State	Zip	Country	Details
City of Hope	RECRUITING	Duarte	California	91010	United States	Details
Emory Winship Cancer Center	NOT_YET_RECRUITING	Atlanta	Georgia	30322	United States	Details
University of Chicago Cancer Center	NOT_YET_RECRUITING	Chicago	Illinois	60637	United States	Details
Beth Israel Deaconess Medical Center	RECRUITING	Boston	Massachusetts	02215	United States	Details
Dana Farber Cancer Institute/Harvard Medical School	RECRUITING	Boston	Massachusetts	02215	United States	Details
Barbara Ann Karmanos Cancer Center	RECRUITING	Detroit	Michigan	48201	United States	Details
Mayo Clinic Rochester	NOT_YET_RECRUITING	Rochester	Minnesota	55905	United States	Details
Washington University Medicine	RECRUITING	St. Louis	Missouri	63110	United States	Details
Hackensack University Medical Center	RECRUITING	Hackensack	New Jersey	07601	United States	Details
Memorial Sloan Kettering Cancer Center	RECRUITING	New York	New York	10022	United States	Details
Mt. Sinai School of Medicine	RECRUITING	New York	New York	10029	United States	Details
Atrium Levine Cancer Institute	NOT_YET_RECRUITING	Charlotte	North Carolina	28203	United States	Details
Tennessee Oncology	RECRUITING	Nashville	Tennessee	37203	United States	Details

*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field